quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:29:00·35d
PRRelease
Waldencast plc logo

Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™

WALD· Waldencast plc
Consumer Discretionary
Original source

Companies

  • WALD
    Waldencast plc
    Consumer Discretionary

Recent analyst ratings

  • Jan 14UpdateJefferies$2.00
  • Nov 25UpdateTelsey Advisory Group$3.00
  • Apr 22UpdateAlliance Global Partners$5.00
  • Dec 16UpdateTD Cowen$4.30
  • Oct 25UpdateCanaccord Genuity$5.00
  • May 1UpdateTelsey Advisory Group$8.00

Related

  • PR30d
    Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin's Age and Restore Visible Youthfulness
  • INSIDER36d
    SEC Form 3 filed by new insider Brousset Michel
  • INSIDER36d
    SEC Form 3 filed by new insider Souza Cristiano
  • INSIDER36d
    SEC Form 3 filed by new insider Thompson Motta Roberto Moses
  • INSIDER36d
    SEC Form 3 filed by Waldencast plc
  • INSIDER36d
    SEC Form 3 filed by Waldencast plc
  • INSIDER36d
    SEC Form 3 filed by Waldencast plc
  • INSIDER36d
    SEC Form 3 filed by Waldencast plc
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022